Gout is common for patients with end stage kidney disease and dialysis provides an extra challenge for providing effective urate lowering therapy (ULT) in this group of patients. A retrospective New Zealand study of more than 200 dialysis patients found more than a quarter (28.2%) of the patients had gout. While most patients with gout ...
Already a member?
Enter your email to keep reading.